Effectiveness and Cost-effectiveness of the T-Control® Catheter in Patients With Acute Urine Retention
Launched by RETHINK MEDICAL SL · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Withdrawn
Keywords
ClinConnect Summary
Potential participants will be identified by the team of healthcare professionals of the emergency department according to the inclusion and exclusion criteria of the study. If the patient meets the criteria, the emergency department team will be able to refer patients directly to the urology department, where the investigator or research assistant will again check the inclusion and exclusion criteria, will invite the patient or their relative/caregiver (if necessary) to participate in the study and will request their informed consent. The catheter insertion will be carried out by the resea...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males with Acute Urine Retention
- • Equal or over 50 years of age
- • Absence of symptoms of infection on the inclusion day
- • Not having been previously catheterized on the day of inclusion
- • Indication of bladder catheterization for 2 weeks
- • Maintained cognitive and physical capacity for self-monitoring the catheter valve
- • Signed consent agreement
- Exclusion Criteria:
- • Current or recent urinary tract infection in the last 2 weeks
- • Use of current treatment/antibiotic in the last 2 weeks
- • Immunocompromised patients (diagnosed with advance cancer, Acquired Immunodeficiency Syndrome,...)
- • Catheter insertion requiring more than 1 attempt
- • Overactive bladder
- • Patients with bilateral obstructive uropathy
Trial Officials
Laura Vera, Dr.
Principal Investigator
Hospital Universitario Insular de Gran Canaria
Adrián Amador, Dr.
Principal Investigator
University Hospital of the Nuestra Señora de Candelaria
About Rethink Medical Sl
Rethink Medical SL is a pioneering clinical trial sponsor focused on advancing innovative healthcare solutions through rigorous research and development. Committed to improving patient outcomes, the company specializes in designing and managing clinical trials that evaluate cutting-edge therapies and medical technologies. With a multidisciplinary team of experts, Rethink Medical SL emphasizes collaboration, transparency, and adherence to the highest ethical standards, ensuring robust data integrity and compliance throughout the clinical research process. Their mission is to bridge the gap between scientific discovery and practical application, ultimately transforming the landscape of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Cruz De Tenerife, , Spain
Las Palmas De Gran Canaria, Las Palmas, Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials